PRA
IBB icon

Parametric Risk Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Parametric Risk Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,690
Closed -$574K – 120
2016
Q2 		$574K Hold
6,690
– – 0.04% 126
2016
Q1 		$582K Buy
+6,690
New +$598K 0.04% 117

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Parametric Risk Advisors's IBB Position: Q3 2016 in Review

Parametric Risk Advisors sold out of iShares Biotechnology ETF (IBB) in Q3 2016, closing a stake of 6,690 shares — an estimated $574K sold.

Parametric Risk Advisors first reported a position in IBB in Q1 2016 and held it in 2 quarters. The position peaked at $582K in Q1 2016. 463 funds tracked by Wall St. Rank hold IBB as of Q3 2016.

  • Parametric Risk Advisors reported no remaining iShares Biotechnology ETF position as of Q3 2016 after selling out during the quarter.
  • Parametric Risk Advisors sold 6,690 iShares Biotechnology ETF shares in Q3 2016, an estimated $574K.
  • Parametric Risk Advisors first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 2 quarters.
  • Parametric Risk Advisors's iShares Biotechnology ETF position peaked at $582K in Q1 2016.
  • 463 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.

Based on Parametric Risk Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.